Back to top
more

Celanese (CE)

(Real Time Quote from BATS)

$89.90 USD

89.90
1,264,771

-2.54 (-2.75%)

Updated Nov 7, 2024 01:33 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 45% (138 out of 251)

Industry: Chemical - Specialty

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Anindya Barman headshot

Celanese (CE) Rallies 48% YTD: What's Driving the Stock?

by Anindya Barman

Celanese (CE) gains on its investments in organic projects, strategic acquisitions and productivity measures.

Celanese (CE) Scales 52-Week High: What's Driving the Stock?

by Zacks Equity Research

Celanese (CE) gains on its productivity measures, investments in organic projects and strategic acquisitions.

Celanese (CE) Up 20.1% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Hold Onto Celanese (CE) Stock For Now

by Zacks Equity Research

Celanese (CE) gains on productivity actions, investments in high-return organic projects and acquisitions amid demand softness and customer de-stocking in certain end markets.

Celanese (CE) Up 25% in 6 Months: What's Driving the Rally?

by Zacks Equity Research

Celanese (CE) benefits from its productivity measures, investments in organic projects and strategic acquisitions.

Celanese (CE) Q3 Earnings Surpass Estimates, Sales Miss

by Zacks Equity Research

Celanese (CE) surpasses earnings estimates in the third quarter on cost-reduction actions.

Celanese (CE) Reports Q3 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

The headline numbers for Celanese (CE) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Mayur Thaker headshot

Markets Rally as Fed Hints at The End of Rate Hikes While Macro Data Worsens

by Mayur Thaker

"Bad news is good news" for now, until the bad news keeps coming.

AdvanSix (ASIX) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

AdvanSix (ASIX) delivered earnings and revenue surprises of -3,700% and 12.23%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Celanese (CE) to Report Q3 Earnings: What's in the Offing?

by Zacks Equity Research

Celanese (CE) is expected to have benefited from its cost actions and contributions of acquisitions amid demand headwinds in certain markets in Q3.

Analysts Estimate Celanese (CE) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Albemarle (ALB) Completes MARBL Joint Venture Restructuring

by Zacks Equity Research

Albemarle (ALB) completes MARBL JV restructuring and takes full ownership of Kemerton facility.

Eastman Chemical (EMN) Benefits From Cost Cuts and Innovation

by Zacks Equity Research

Eastman Chemical (EMN) gains on cost-management actions and innovation amid challenges from soft demand and consumer de-stocking in certain markets.

DuPont (DD) Unveils Low-Cyclics Silicone Soft Skin Adhesive

by Zacks Equity Research

The adhesive is created as part of DuPont's (DD) efforts to broaden its portfolio of solutions to support the expanding medical device market.

Here's Why You Should Retain Celanese (CE) in Your Portfolio

by Zacks Equity Research

Celanese (CE) gains on productivity actions, investments in high-return organic projects and acquisitions amid demand softness and customer destocking in certain end markets.

Celanese (CE) Shares Up 21% YTD: What's Driving the Stock?

by Zacks Equity Research

Celanese (CE) benefits from its productivity measures, investments in organic projects and strategic acquisitions.

DuPont (DD) Benefits From Innovation and Spectrum Acquisition

by Zacks Equity Research

While DuPont (DD) faces headwinds from sluggishness in some markets, it benefits from innovation, the Spectrum Plastics acquisition and pricing and productivity actions.

PPG-Dutch University Partner to Build 1st Off-Road Solar Car

by Zacks Equity Research

PPG will supply PPG CoraChar fire protection coating to protect the vehicle's lithium (Li)-ion battery pack.

Abhinab Dasgupta headshot

Take the Zacks Approach to Beat the Market: Shopify, Caterpillar, Amgen in Focus

by Abhinab Dasgupta

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

Celanese (CE) Closes Food Ingredients JV Formation With Mitsui

by Zacks Equity Research

Celanese (CE) monetizes the majority of its Food Ingredients business while maintaining the demand benefits of raw material integration with the Acetyl Chain.

Abhinab Dasgupta headshot

Beat the Market the Zacks Way: Automatic Data Processing, Casey's, Paysafe in Focus

by Abhinab Dasgupta

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

Celanese (CE) Inks Deal With Population Council for VitalDose

by Zacks Equity Research

The VitalDose platform by Celanese (CE) Delivery Platform has a long history of application in approved parenteral drug options.

Celanese (CE) Up 0.8% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Celanese (CE) Refinances Debt to Extend Maturity & Reduce Costs

by Zacks Equity Research

Celanese (CE) is refinancing its debt to extend the maturity of its debt and reduce its borrowing costs by 14 basis points.

Celanese (CE) Q2 Earnings and Sales Fall Short of Estimates

by Zacks Equity Research

Celanese (CE) misses second-quarter earnings and sales estimates due to slow demand recovery and production cuts.